Vulvovaginal candidiasis (VVC) is an infection caused by Candida species that affects
millions of women every year. Although Candida albicans is the main cause of VVC, the …

Abstract Approximately 70‐75% of women will have vulvovaginal candidosis (VVC) at least
once in their lifetime. In premenopausal, pregnant, asymptomatic and healthy women and …

Despite therapeutic advances, vulvovaginal candidosis remains a common problem
worldwide, affecting all strata of society. Understanding of anti-candida host defence …

Although a number of fungal species belonging to the genus C andida can cause acute
vulvovaginal infection (VVC), C andida albicans is by far the most prevalent etiological …

abstract Exposure and sensitization to fungal allergens can promote the development and
worsening of allergic diseases. Although numerous species of fungi have been associated …

Vulvovaginal candidosis (VVC) is a frequently occurring infection of the lower female genital
tract, mostly affecting immuno-competent women at childbearing age. Candida albicans is …

The oestrogenised vagina is colonised by Candida species in at least 20% of women; in late
pregnancy and in immunosuppressed patients, this increases to at least 30%. In most cases …

The first fully synthetic glycopeptide vaccines against a fungal disease have been used to
combat disseminated candidiasis in mice. Six T cell peptides found in Candida albicans cell …

Candida (C.) species colonize the estrogenized vagina in at least 20% of all women. This
statistic rises to 30% in late pregnancy and in immunosuppressed patients. The most often …

Patients with diabetes, especially those with poorly controlled glycemia, are prone to
developing genital mycotic infections—vulvovaginal candidiasis in women and Candida …